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A spontaneous leptin receptor point mutation
causes obesity and differentially affects leptin
signaling in hypothalamic nuclei resulting in
metabolic dysfunctions distinct from db/db mice
Federica Piattini 1,3, Christelle Le Foll 2,3, Jan Kisielow 1, Esther Rosenwald 1, Peter Nielsen 1, Thomas Lutz 2,
Christoph Schneider 1, Manfred Kopf 1,*
ABSTRACT
Objective: Leptin (Lep) plays a crucial role in controlling food intake and energy expenditure. Defective Lep/LepRb-signaling leads to fat
accumulation, massive obesity, and the development of diabetes. We serendipitously noticed spontaneous development of obesity similar to
LepR-deﬁcient (db/db) mice in offspring from a C57BL/6J breeding and transmittance of the phenotype in a Mendelian manner. Candidate gene
sequencing revealed a spontaneous point mutation in the LepRb gene. We investigated leptin responsiveness, leptin receptor signaling and
metabolic phenotype of this novel LepRb mutant mouse variant.
Methods: Overexpression and functional tests of the mutant LepRb in 3T3 cells. Measurement of leptin responsiveness in hypothalamic nuclei,
glucose tolerance, food uptake and energy expenditure in the mutant mice.
Results: The mutation results in the exchange of a glycine for serine (G506S) and introduces an alternative splice acceptor which, when used,
encodes for a protein with a 40aa deletion that is retained in the cytoplasm. LepRb signaling was abrogated in the hypothalamic ventromedial
nucleus (VMN) and dorsomedial nucleus (DMN), but only partially reduced in the hypothalamic arcuate nucleus (ARC) of LepRbG506S/G506S mice,
most likely due to differential splicing in neurons located in the respective regions of the hypothalamus. Extensive metabolic characterization of
these mice revealed interesting differences in the control of food intake, glucose tolerance, energy expenditure, and fat accumulation in
LepRbG506S/G506S compared with LepRb-deﬁcient db/db mice.
Conclusions: This study provides further insight into differences of the leptin responsiveness in VMN, DMN, and ARC and its metabolic
consequences.
 2019 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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1. INTRODUCTION
Leptin is produced by adipose tissue, and its concentrations are pro-
portional to the amount of body fat mass but also ﬂuctuate in response
to food intake [1]. Leptin reaches the brain via the bloodstream and
binds to the leptin receptor expressed on neurons of the hypothalamus.
Leptin binding induces the tetramerization of the long form of leptin
receptor LepRb [2], and the resulting downstream signaling leads to
the repression of food intake in a negative feedback loop [3,4].
Leptin deﬁcient (ob/ob) and leptin receptor deﬁcient (db/db) mice are
markedly obese from 4 weeks of age due to excessive food intake [5e
8]. The mutation in db/db mice results in an alternatively spliced leptin
receptor RNA with a 106 bp deletion [9]. This deletion in the intra-
cellular region of the long isoform of leptin receptor prevents signal
transduction and therefore causes unresponsiveness to circulating
leptin [10].
Leptin is mostly known for repressing appetite but it also controls other
vital functions such as energy expenditure (EE), insulin sensitivity and
glucose homeostasis [11,12]. Indeed, ob/ob and db/db mice have
increased body weight and show increased blood insulin, resulting from
an attempt to compensate for the insulin resistance generated by the
increased concentration of glucose in the blood. In addition, these mice
also develop a fatty liver and hypercholesterolemia and are infertile [13e
15]. Obesity and associated metabolic diseases are not entirely deter-
mined by increased food intake, since leptin-deﬁcient mice, compared to
lean mice, still accumulate fat and body weight when caloric uptake is
restricted. This points to an important role of leptin in controlling energy
expenditure independent of food intake [13].
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The brain is the main target for the weight-reducing and neuro-
endocrine effects of leptin, as indicated by development of obesity
in mice lacking LepRb speciﬁcally in neurons [16]. Conversely,
reconstitution of LepRb in neurons of db/db mice reduces obesity
[17]. Furthermore, leptin administration directly to the brain of both
ob/ob and WT mice reduces food intake and body weigh t [18]. A
particularly high expression of LepRb is observed in the arcuate
nucleus (ARC), ventromedial nucleus (VMN), and dorsomedial nu-
cleus (DMN) of the hypothalamus [19,20]. In the ARC, neurons
expressing LepRb can be further divided into anorexigenic proo-
piomelanocortin (POMC)-expressing neurons and orexigenic,
agouti-related peptide (AgRP)-expressing neurons or neuropeptide
Y (NPY) neurons [21,22]. Under homeostatic conditions, leptin
stimulates catabolic POMC neurons and POMC expression [21,23]
but inhibits AgRP neurons and AgRP expression [24,25]. POMC
neurons then release the catabolic neuropeptide a-melanocyte
stimulating hormone (aMSH), which acts on melanocortin 3 and 4
receptors (MCR3/4) particularly in the paraventricular nucleus of
the hypothalamus, to reduce food intake and increase energy
expenditure via thermogenesis. AgRP serves as a potent endoge-
nous antagonist (inverse agonist) of MCR3/4 [26]. NPY/AgRP
neurons synapse onto POMC neurons to provide inhibitory action
via release of NPY onto NPY receptor type 2 (Y2) and gamma-
aminobutyric acid (GABA), further supporting a tightly regulated
neuronal network (reviewed in [27,28]).
In obesity models based on Lep/LepR-deﬁciency, hypothalamic POMC
levels are downregulated, while AgRP and NPY are increased and
administration of leptin in ob/ob mice reverses this effect [24,29,30].
Several studies have demonstrated that the various metabolic func-
tions of leptin are controlled by different neurons. Leptin speciﬁcally
activates SF1 neurons in the VMN to stimulate the sympathetic nervous
system [31]. In addition, SF1 neurons are required for the control of
energy expenditure [32,33].
Other studies focusing on POMC neurons showed that even though
they have little inﬂuence on the control of food intake, they are
required for glucose homeostasis. Re-expression of LepRb selec-
tively in POMC neurons in mice that were otherwise LepRb-deﬁcient,
normalized hyperglycemia but was insufﬁcient to control food intake
and the development of obesity [34e36], implying that POMC neu-
rons are sufﬁcient for glucose homeostasis. Similarly, selective re-
expression of LepRb in AgRp neurons also normalized hyperglyce-
mia in db/db mice, showing that AgRP neurons are sufﬁcient for
leptin’s anti-diabetic effect [37]. Another hypothalamic region
expressing high levels of leptin receptor is the DMN, which is
responsible for leptin-mediated thermoregulation and thereby energy
homeostasis [38].
Overall, it seems that there are subtle differences in the role of the
various neurons expressing leptin receptor, but this does not
exclude that some functions are redundantly shared by many
neuron types.
We here describe a novel spontaneous point mutation of the LepRb
gene in mice, leading to a truncated protein that predominantly
affects LepRb signaling in the ventromedial and dorsomedial nu-
cleus of the hypothalamus. Partial responsiveness to leptin in
homozygous mutants resulted in differences in the control of en-
ergy expenditure and the severity of diabetes compared to db/db
mice, although the development of obesity was comparable to full
KO mice. These effects could be the result from the difference in
LepRb expression and highlight the importance of the ARC in
controlling energy homeostasis.
2. MATERIAL AND METHODS
2.1. Mice
Mice were maintained in a temperature-controlled (21  2 C)
room on a 12:12 h light/dark schedule with lights off at 1800 h.
Food and water were provided ad libitum. The animals were fed
standard chow diet (Diet 3436, Provimi Kliba AG, Kaiseraugst,
Switzerland). C57BL/6 mice with the LepRbG506S mutation were
maintained by crossing homozygous and heterozygous mice.
Littermate controls were used in all experiments. C57BL/6 mice
were obtained from the animal facility at ETH. Animals were kept
in individually ventilated cages under speciﬁc pathogen-free
conditions at the ETH Phenomics center. LepRb LoxTB
[B6.129X1(FVB)-Leprtm1Jke/J, no. 019111; The Jackson Labora-
tory], and wildtype (WT) littermates were bred in the UZH LASC
facility. LepRb LoxTB mice possess a transcriptional blocker
cassette that prevents the transcription of the LepRb gene [35,39].
db/db mice were purchased from Janvier Labs.
Prior to transfer to metabolic cages, mice were single-housed for
adaptation for several days. All experiments were approved by the local
Ethics Committees and were performed according to local guidelines
and Swiss animal protection law.
2.2. Glucose and insulin tolerance test
Mice were fasted for 6 hours, and blood was sampled by tail nip for a
baseline measurement. 2 g glucose/kg body weight or 0.5 IU insulin/kg
body weight was then injected intraperitoneally (i.p.) and plasma
glucose was measured after 15, 30, 60, 90, 120 and 180 minutes.
Water was available ad libitum during the entire experiment.
2.3. Food intake
Metabolic and food intake measurements were performed in single-
housed conditions in an automated monitoring system (Pheno-
Master, TSE System). Before 24h-food intake measurements, mice
were fasted for 2 hours, prior to dark onset.
2.4. Indirect calorimetry
The TSE PhenoMaster open circuit indirect calorimetry system for
the determination of O2 consumption and CO2 production (TSE
Systems; Bad Homburg, Germany) was used. Room air was passed
through each cage at a ﬂow rate of 0.41 L/min. Every 20 min,
cage air was sampled from each individual cage and analyzed for
O2 and CO2. From these values, energy expenditure (EE) and
respiratory exchange ratio (RER) were calculated, based on the
equations from Weir [40]. To account for differences in body
weight and body mass composition, EE data were corrected for
individual lean body mass (LBM in g) and fat mass (FM in g) using
the following equation: LBM þ 0.2FM, as recommended by Even
and Nadkarni [41].
2.5. Measurement of body composition
CT scanning was performed using a La Theta LCT-100 (Hitachi
Aloka Medical Ltd, Steinhausen, Switzerland). Mice were
placed supine in the plexiglass holder with an inner diameter
of 48 mm. The X-ray source tube voltage was set at 50 kV
with 1 mA current. The entire body without head was evalu-
ated for lean and fat mass. LaTheta LCT-100 software auto-
matically distinguishes between visceral and subcutaneous
fat; however, each image was examined and corrected if
assigned incorrectly.
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2.6. Analysis of plasma leptin, insulin, cholesterol and triglycerides
Blood was collected at sacriﬁce by heart puncture in K-EDTA tubes and
was centrifuged at 10 000 rpm for 10 min and the plasma was stored
at 80 C until further processed. Insulin and leptin concentrations
were determined in a 2-plex mesoscale assay (Mesoscale, MD, USA)
following manufacturer’s instructions. Cholesterol and triglycerides
were measured with enzymatic photometric tests using the
COBAS8000 autoanalyzer, both from Roche diagnostics (Rotkreuz,
Switzerland).
2.7. Immunohistochemistry
2.7.1. Brain perfusion
Mice were fasted for 2h and at dark onset were injected with saline vs.
leptin (i.p. 5 mg/kg, PeproTech, UK) and 45 min later perfused for
1.5 min with saline and 5 min with 2% paraformaldehyde in 0.1 M
phosphate buffer (PB-PFA, pH 7.4). Brains were post-ﬁxed for 2h in 2%
PB-PFA and dehydrated overnight in 20% sucrose-0.1M PB. They were
then frozen in hexane on dry ice for 3 min and stored at 80 C.
Frozen brains were sectioned serially at 25 mm through the ARC and
VMN on a cryostat, sections were mounted onto superfrost plus slides
(Life Technologies Europe, Zug, Switzerland) and stored in cryopro-
tectant (50% 0.02 M KPBS, 30% ethylene glycol, 20% glycerol)
at 20 C until staining for leptin-induced pSTAT3 and POMC
immunocytochemistry (IHC) in the ARC.
2.7.2. pSTAT3 and POMC IHC
Brain slides were rinsed in 0.02 M potassium phosphate saline buffer
(KPBS) and pre-treated for 20 min in KPBS containing 0.5% NaOH and
0.5% H2O2. After rinsing, brain slides were incubated in 0.3% glycine
in KPBS, rinsed in KPBS and incubated for an additional 10 min in
KPBS containing 0.03% SDS. Following rinses, slides were incubated
in blocking solution containing 0.4% Triton X-100, 1% BSA and 4%
normal goat serum (NGS) in KPBS for 1h followed by incubation at 4 C
for 48 h in modiﬁed blocking solution (0.4% Triton X-100, 1% BSA and
1% NGS) containing rabbit anti-pSTAT3 antibody (1:1000; Cell
Signaling Technologies, BioConcept, Allschwil, Switzerland). After
rinsing with KPBS, slides were incubated with secondary antibody (CY3
goat anti-rabbit, 1:250; Jackson Laboratories, Luzern, Switzerland) in
KPBS for 2 h. After rinses in KPBS, slides were coverslipped with
Vectashield hardset mounting medium (Vectorlabs, Servion,
Switzerland).
In a second series, double-label pSTAT3-POMC IHC was carried out.
The same pSTAT3 IHC protocol as above was followed. Sections were
then incubated in blocking solution containing 0.4% Triton X-100, 1%
BSA and 4% NGS in KPBS for 1h followed by incubation at 4 C for 72 h
in modiﬁed blocking solution (0.4% Triton X-100, 1% BSA and 1%
NGS) containing rabbit anti-POMC antibody (1:1000; Phoenix Phar-
maceuticals). Following rinses, sections were placed in Alexa-Fluor
488 goat anti-rabbit for 2 h (1:250; Life Technologies Europe, Zug,
Switzerland), rinsed again and mounted using Vectashield hardset
mounting medium [42].
2.7.3. Quantitative analysis of immunolabeled cells
Labeled cells were imaged using an L2 Imager upright microscope
(Zeiss, Germany). Images of single and double labeled cells were
counted using ImageJ (NIH) to allow for quantiﬁcation. Three sections
per brain were used for quantiﬁcation. Slides were numerically coded
to obscure the treatment group. To ensure similar imaging conditions
for all images, the same microscope set-up and acquisition settings
were used to acquire all images within the same experiment. For
representative images, images were equally adjusted for brightness
and contrast within the same experiment [39].
2.8. Isolation of ARC and RNA extraction
Mice were sacriﬁced by pentobarbital injection (100 mg/kg) 2 hours
post starvation, and brains were snap frozen on dry ice. The brain were
then mounted on a cryostat and cut in 250 mm sections through the
ARC. ARC was punched out and stored at80 C until RNA extraction.
Total RNA of cells or lysates was extracted using TRIzol (Life Tech-
nologies), followed by reverse transcription using GoScript Reverse
Transcriptase (Promega) according to the manufacturer’s instructions.
LepR fragments were PCR ampliﬁed semi-quantitatively using oligo-
nucleotides LepR(for)50-gacttgcagatggtcacc-30 and LepR(rev):50-
tgcacagaggtctgacac-3’.
2.9. Transduction of 3T3 cells
The wild-type LepRb coding region was ampliﬁed from brain cDNA and
used to create LepRbG506S and LepRbD40aa prior to cloning into pMY
vector carrying a GFP reporter. The plasmid was introduced into
Phoenix cells, supernatant containing retrovirus was collected after 2
and 3 days and concentrated. Spin infection of 3T3 cells was per-
formed at 37 C for 45 minutes. GFPþ cells were sorted using a ﬂow
cytometry cell sorter (BD FACS ARIA IIIu). For double transductions,
LepRbD40aa was transferred into the pMY vector carrying a dsRed2
reporter. Virus was produced as described and used to spin infect 3T3
cells that already overexpressed LepRbWT or LepRbG506S.
GFPþdsRed2þ cells were FACS sorted.
2.10. Leptin stimulation of 3T3 cells
Cells were kept overnight in IMDM medium (ThermoFisher) with 100 U/
mL Penicillin-Streptomycin (ThermoFisher) and 50 mM b-mercaptoe-
thanol (ThermoFisher), without FBS. Various concentrations of leptin or
BSA as a negative control were added for 30 minutes prior to trypsi-
nization and collection of the cells for staining.
2.11. Staining and FACS analysis
Leptin receptor staining was performed using an a-leptin receptor
antibody from R&D systems (polyclonal goat IgG, 1:300). Extracellular
staining was performed in PBS þ 2% FBS for 15 minutes. Intracellular
staining was performed after 5 minutes ﬁxation with 4% para-
formaldehyde followed by 5 minutes permeabilization with 0.5%
saponin in PBS þ 2% FBS.
pSTAT3 staining (pY705, BD Biosciences, clone 4/P-STAT3) was
performed diluting the antibody 1:5 in 2% FBS in PBS after 10 minutes
ﬁxation with 4% paraformaldehyde followed by permeabilization with
90% ice-cold methanol for 20 minutes.
Cells were acquired on BD FACS Canto II and analyzed with FlowJo
software (Tree Star).
2.12. Western Blot
3T3 cells were lysed with RIPA buffer (20 mM Tris-HCl, pH 7.5,
150 mM NaCl, 5 mM EDTA, 1 mM Na3VO4, 1% Triton X-100, sup-
plemented with protease inhibitor [SigmaeAldrich] and phosphatase
inhibitor [SigmaeAldrich]). Samples were then spun at 4 C to remove
all cell debris and protein concentrations were determined using the
PierceTM BCA Protein Assay Kit (Thermo Scientiﬁc). 5 mg of proteins
were fractionated by SDS-PAGE and transferred to a Polyvinylidene
diﬂuoride (PVDF) membrane using a transfer apparatus according to
manufacturer’s instructions (Bio-Rad). After blocking with 4% nonfat
milk in TBST (50 mM Tris, pH 8.0, 150 mM NaCl, 0.1% Tween 20) for
45 min, the membrane was incubated with primary antibodies in 4%
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nonfat milk in TBST (Phospho-p44/42 MAPK (ERK1/2) (Thr202/
Tyr204), 1:1000, Cell Signaling Technology) at 4 C for 16 h. After
washing, membranes were incubated with horseradish peroxidase-
conjugated anti-rabbit antibody in 4% nonfat milk in TBST (Goat
Anti-Rabbit IgG(H þ L), Mouse/Human ads-HRP, Biozol) at RT for 1
hour. Blots were washed with TBST three times and developed with
the ECL system (Thermo Scientiﬁc) according to manufacturer’s in-
structions. After acquisition with ChemiDoc MP Imaging System (Bio-
Rad) using Image Lab program, membrane was stripped by incubating
it two times 8 minutes with stripping buffer (1.5% glycine, 0.1% SDS,
1% Tween, pH 2.2), followed by two times with PBS and two times
with TBST and ﬁnally blocked again for 45 minutes with 4% nonfat
milk in TBST. Horseradish peroxidase-conjugated b-Actin antibody
was incubated in 4% nonfat milk in TBST for 45 minutes at RT(AC-15;
SigmaeAldrich).
2.13. Statistics
GraphPad Prism 7 was used for all representations and statistical
analysis. Mean and SD or mean and SEM are shown as described in
the ﬁgure legend. One-Way ANOVA, two-way ANOVA, and Student’s t-
test were used for statistics. RMarkdown was used for ANCOVA
analysis.
3. RESULTS
3.1. A spontaneous point mutation in the leptin receptor gene is
associated with the development of obesity in LepRbG506S/G506S
similar to db/db mice
We serendipitously noticed that a breeding pair of C57BL/6 mice
delivered offspring, some of which developed early onset obesity; this
phenomenon was seen in both sexes (Figure 1A). When obese mice
were bred with lean wild-type C57BL/6 mice and the F1 was interbred,
transmission of the phenotype was Mendelian. Both males and fe-
males gained weight much faster compared to lean littermates and the
difference was already discernible and statistically signiﬁcant in 4
week-old males and 5 week-old females (Figure 1B). Genome
sequencing revealed a single base pair mutation in the leptin receptor
gene (G > A) at position 1516 from the ATG start codon (Figure 1C).
This mutation causes an exchange of a glycine with a serine at position
506 (G506S) and homozygous mice were therefore dubbed
LepRbG506S/G506S. In addition to the single amino acid exchange, the
mutation also generated a new potential splice acceptor site, which
would lead to an alternatively spliced mRNA and a protein with an
internal deletion of 40 amino acids, including one of the two amino
acids crucial for leptin binding. To address this possibility, we isolated
the ARC from the hypothalamus, prepared cDNA, and semi-quantitively
PCR ampliﬁed LepRb using primers that span the region including the
potential splice product. In the ARC of homozygous LepRbG506S/G506S
mice, besides the LepRb wild-type fragment, we identiﬁed a band
corresponding in size and sequence to the product of the alternatively
spliced RNA (LepRbD40aa, Figure 1D). The LepRbD40aa fragment was
absent in WT mice. Therefore, we hypothesized that this mutation was
responsible for the development of obesity in LepRbG506S/G506S mice.
The increase in body weight of male LepRbG506S/G506S and db/db mice
was comparable only until 9e10 weeks of age (Figure 1E). Thereafter,
the increase in body weight was not as pronounced in LepRbG506S/
G506S mice as it was for db/db.
3.2. A truncated LepRb due to alternative splicing is not
transported to the cell surface and does not signal in response to
leptin
To investigate how the point mutation inﬂuences surface expression
and leptin signaling, we generated ﬁbroblast cell lines overexpressing
the three different forms of leptin receptor. 3T3 cells were transduced
Figure 1: Spontaneous mutation in leptin receptor gene leads to development of obesity. (A) Picture of a three months old obese LepRbG506S/G506S and a lean LepRbG506S/þ
mouse. (B) Body weight of male and female LepRbG506S/G506S and heterozygous LepRbG506S/þ littermates with age after weaning (n ¼ 3e6/group). (C) Nucleotide and amino acid
sequences from Q498 to I511 of wild-type (top) and mutant (bottom) leptin receptor. (D) ARC nuclei from wild-type and homozygous mutants (n ¼ 3/group) were isolated and cDNA
prepared. Semiquantitative PCR was performed using oligonucleotides ﬂanking the G506S point mutation and allow identiﬁcation of both the wild-type (481 bp) and alternatively
spliced LepRb (361 bp) products. (E) Body weight of male LepRbG506S/G506S, db/db, and respective heterozygous controls (n ¼ 6e11/group). Values in (B) and (E) show
mean  standard deviation. ***, P < 0.0021, ****, P < 0.0002.
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with retroviruses expressing GFP together with the LepRb wild-type
transcript (LepRbWT), a transcript with the point mutation
(LepRbG506S) or a transcript with the deletion corresponding to the
product of the alternatively spliced RNA (LepRbD40aa). GFP þ cells
were sorted and leptin receptor expression was measured by ﬂow
cytometry. Figure 2A shows that the leptin receptor WT and G506S
mutant were comparably expressed. In contrast, the alternatively
spliced form was not detected on the cell surface, while it could be
detected by intracellular staining (Figure 2B), indicating that the protein
is produced but cannot be transported to the cell surface. It is possible
that cells expressing LepRb in obese LepRbG506S/G506S mice produce
varying levels of the two alternatively spliced transcripts and therefore
two protein forms: a LepRb with a point mutation and a truncated
LepRb with a 40aa deletion. Since the leptin receptor needs to dimerize
in order to be expressed on the cell surface [2], it was theoretically
possible that the truncated LepRbD40aa protein acts in a dominant
negative way by preventing dimerization with and/or cell surface
translocation of the LepRbG506S with the point mutation. To investigate
this, we generated 3T3 cells overexpressing both LepRbG506S (or
LepRb WT) and LepRbD40aa simultaneously. Co-expression of dsRed
and GFP reporters was used to select for double positive cells
expressing both LepRb variants. Staining for the leptin receptor in
double transformed cells indicated that the presence of LepRbD40aa
was not sufﬁcient to prevent transport of the full-length receptor to the
surface (Figure 2C). It is important to note that this system has the
limitation that the leptin receptors are most likely not expressed at
levels comparable to what is observed in neurons of the hypothalamus.
The overexpression could bypass the hypothesized dominant negative
effect by producing enough of the longer form as homodimers which
can be detected on the surface. Nevertheless, it indicates that if
enough of the full-length form is present, it can be expressed on the
cell surface.
The phenotype in LepRbG506S/G506S mice could be due either to
alternative splicing of all leptin receptor gene transcripts, and therefore
absence of cell surface expression, or to an inability of the single amino
acid mutated form to bind leptin and transduce the signaling. To test
the latter hypothesis, we starved 3T3 cells overexpressing the different
receptor forms and then added leptin to measure the phosphorylation
of STAT3 and ERK. Importantly, STAT3 and ERK activation were
comparably strong in cells expressing either LepRbG506S or WT LepRb
(Figure 2D,E), while cells expressing the alternatively spliced form
LepRbD40aa failed to respond to leptin. We conclude that the point
mutation is not responsible for defective leptin signaling in LepRbG506S/
G506S mice.
3.3. Differential response to leptin in the ventromedial and arcuate
nucleus of the hypothalamus of LepRbG506S/G506S mice
The metabolic activity of leptin is mainly determined in the hypothal-
amus by binding to the LepRb and triggering STAT3 activation in
neurons of the arcuate nucleus and ventromedial nucleus of the hy-
pothalamus [43,44]. To monitor LepRb signaling in the brain,
LepRbG506S/G506S, db/db, and WT control mice were fasted for 2 hours
prior to injection of leptin and sacriﬁced 45 minutes later as previously
published [45]. Expectedly, immunohistochemical staining of medio-
basal hypothalamus sections showed abundant pSTAT3 positive
neurons in both the VMN and ARC of WT mice (Figure 3A,B), which was
undetectable in db/db mice, consistent with a complete unrespon-
siveness to leptin. Interestingly, LepRb signaling was also abrogated in
the VMN of LepRbG506S/G506S mice, while the number of pSTAT3þ
neurons in the ARC was only reduced to about one half of controls,
pointing to an important difference between db/db and LepRbG506S/
G506S mice in particular in respect to the activation of ARC neurons.
The ARC consists of at least two types of neurons, anorexigenic POMC
and orexigenic AgRP, both of which are known to respond to leptin.
Concomitant staining of pSTAT3 and POMC revealed a comparable
number of pSTAT3þ POMC neurons in heterozygous LepRbG506S/þ and
LepRbG506S/G506S mice (Figure 3C,D), suggesting that the decrease in
leptin-induced pSTAT3 seen in the ARC is not due to a decrease in
leptin signaling in POMC neurons. Another brain region exerting an
important role in energy expenditure is the DMN. As for the VMN, DMN
leptin-induced pSTAT3 was almost absent in LepRbG506S/G506S mice
(Figure 3E,F).
Figure 2: The alternatively spliced form of the leptin receptor is not expressed on the cell surface. (A) 3T3 cells were transduced with retroviral vectors encoding either
LepRbWT-IRES-GFP, LepRbG506S -IRES-GFP, or LepRbD40aa-IRES-GFP. GFP þ cells were sorted and expression of leptin receptor was analyzed by ﬂowcytometry. (B) Intracellular
staining for leptin receptor in transformed 3T3 cells as in (A). (C) Expression of leptin receptor on the surface of 3T3 cells transduced consecutively with LepRbWT-IRES-GFP and
LepRbD40aa-IRES-dsRed2 or LepRbG506S-IRES-GFP and LepRbD40aa-IRES-dsRed2. (D) Induction of leptin signaling measured by phosphorylation of STAT3, 30 minutes after
stimulation of transformed 3T3 cells with the indicated concentrations of leptin. US indicates unstimulated cells, BSA (0.5%) was used as unspeciﬁc stimulus. (E) Induction of leptin
signaling measured by phosphorylation of ERK, 30 minutes after stimulation of transformed 3T3 cells. US indicates unstimulated cells, OVA (50 ng/mL) was used as unspeciﬁc
stimulus.
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3.4. Differences in glucose tolerance and subcutaneous fat
accumulation in LepRbG506S/G506S and db/db mice
Since leptin signaling is abrogated in VMN but only partially affected in
the ARC of LepRbG506S/G506S mice, we decided to further investigate
the animals’ phenotype, in particular by focusing on metabolic dif-
ferences compared to db/db.
LepRbG506S/G506S, db/db and control mice were subjected to computed
tomography (CT) to determine their body weight composition.
Consistent with the obese phenotype, LepRbG506S/G506S mice had
increased fat mass compared to littermates (Figure 4A,B). However,
when compared to db/db mice, we found that even though the total
weight was proportionally similar, LepRbG506S/G506S mice had more
lean mass and less subcutaneous fat.
A glucose tolerance test showed that fasting plasma level of glucose in
LepRbG506S/G506S mice was signiﬁcantly lower compared to age
matched db/db mice and only slightly elevated compared to WT
Figure 3: STAT3 signaling is signiﬁcantly impaired in the arcuate nucleus (ARC) and completely abrogated in the ventromedial nucleus (VMN) and dorsomedial
nucleus (DMN) in the hypothalamus of LepRbG506S/G506S mice. (A and E) Immunohistochemistry of pSTAT3 on brain slices. (B) Quantiﬁcation of pSTAT3-positive neurons in the
ARC and in the VMN. Data of 2 separate experiments were pooled, in one experiment db/db were replaced by LepRloxTB/loxTB mice. (C) Co-staining of pSTAT3 and POMC on brain
sections. (D) Quantiﬁcation of POMC positive neurons and frequency of double positive neurons among POMC positive neurons. (F) Quantiﬁcation of pSTAT3-positive neurons in the
DMN. Mice were fasted for 2h prior to leptin injection and brains were removed 45 min later. Values represent mean with standard deviation (n ¼ 3e6/group). *, P < 0.1234; **,
P < 0.0332; ***, P < 0.0021, ****, P < 0.0002.
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littermates (Figure 4C). The difference between LepRbG506S/G506S and
WT controls disappeared when plasma glucose was normalized to
body weight (Figure 4D). LepRbG506S/G506S mice were glucose intol-
erant (Figure 4E); however, glucose levels came back to baseline faster
than in db/db mice. It should be noted that blood glucose levels of db/
db mice exceeded upper detection limit of the device at several time
points indicating that peak level of db/db mice is higher than depicted.
Despite differences in glucose metabolism, both LepRbG506S/G506S and
db/db mice showed comparable insulin resistance during the ITT
(Figure 4F).
In addition to plasma glucose, we also measured other parameters
typically associated with obesity. As expected, plasma insulin was
Figure 4: Differences in metabolic parameters of 20 weeks old db/db and LepRbG506S/G506S mice. (AeB) Distribution of body mass in subcutaneous fat, visceral fat and lean
mass represented as percentage of total body weight or gram of different tissues. (C) Fasting glucose levels. (D) Fasting glucose levels normalized to body weight. (E and F)
Glucose and insulin tolerance test. Stars indicate comparison to controls, squares indicate comparison between db/db and LepRbG506S/G506S mice. (GeJ) Fasting plasma levels
of insulin (G), leptin (H), cholesterol (I) and triglycerides (J). (AeD) and (GeJ) values represent mean and standard deviation, (E and F) values represent mean and standard error.
CeE: n ¼ 7e11; A, B, G, I, J: n ¼ 6; F: n ¼ 4e6; H: n ¼ 3. *, P < 0.1234; **, P < 0.0332; ***, P < 0.0021, ****, P < 0.0002.
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signiﬁcantly increased in LepRbG506S/G506S mice compared to WT
(Figure 4G). Interestingly, it was also increased in comparison to db/db
mice. Both plasma leptin and cholesterol were signiﬁcantly higher in
LepRbG506S/G506S compared to WT mice and levels were comparable to
those of db/db mice (Figure 4H,I). However, in contrast to db/db mice,
triglycerides were not elevated in LepRbG506S/G506S mice (Figure 4J).
Overall, these data show that while sharing many aspects of obesity,
LepRbG506S/G506S mice are not as glucose intolerant as db/db and
accumulate less fat.
3.5. Energy expenditure and food intake are differently regulated in
LepRbG506S/G506S and db/db mice
To investigate the metabolic state of LepRbG506S/G506S mice, they were
put into metabolic cages and food intake, energy expenditure, oxygen
consumption and CO2 production during day and night were deter-
mined and compared to db/db mice. As expected by the increased
body weight, both db/db and LepRbG506S/G506S mice consumed more
food than lean littermates (Figure 5A), but a difference was observed
during the light phase, when db/db mice continued to eat, in contrast
to the other groups. LepRbG506S/G506S mice ate until the very end of the
dark phase while WT and heterozygous controls already reduced food
consumption few hours before the end of the dark phase. Body weight
of LepRbG506S/G506S and db/db mice was comparable at the time when
this measurement was performed.
The respiratory exchange ratio (RER, Figure 5B) also revealed a dif-
ference between LepRbG506S/G506S and db/db mice. While LepRbG506S/
G506S and control groups switched from using carbohydrate oxidation
(RER 1.0) during the dark phase to lipid oxidation (RER 0.7 if only fat is
oxidized) during the light phase as an energy source, the RER of db/db
mice did not differ markedly between day and night, which may be
explained by continued food intake of db/db but not LepRbG506S/G506S
mice during day time.
Finally, we compared energy expenditure to determine if this could
explain the difference in fat mass observed between LepRbG506S/G506S
mice and db/db. Indeed, during the light phase, LepRbG506S/G506S mice
had an EE that was comparable to lean controls, whereas it was
increased in db/db (Figure 5C). This difference became more obvious
when looking at EE after a 2 hour fast (Figure 5D), when EE in
LepRbG506S/G506S mice and control wild-type were comparably low
while db/db’s EE was elevated. ANCOVA analysis of EE and
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Figure 5: Inhibition of food intake is compromised in LepRbG506S/G506S mice, but energy expenditure is comparable to lean littermates. (A) Food intake during 24 hours
following 2 hours starvation, starting from 12 hours of dark. Values represent mean and standard error, stars indicate comparison to controls. (B) Respiratory exchange ratio and
average of 12 hours dark or light. (C) Energy expenditure and sum of 12 hours dark or light. (D) Energy expenditure after 2 hours fasting and sum of 12 hours dark or light. (BeD)
Dots represent mean; bars represent mean and standard deviation. n ¼ 4 or 6/group. *, P < 0.05; **, P < 0.01; ***, P < 0.001, ****, P < 0.0001.
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LBMþ0.2FM, as recommended by Tschöp et al. [46], conﬁrmed that
the difference in EE is largely due to the mouse genotype and has very
little correlation with LBMþ0.2FM (Supplementary Figure 1), con-
ﬁrming the analysis of EE normalized to LBMþ0.2FM.
Taken together, these results indicate that LepRbG506S/G506S and db/db
mice differ in the control of energy expenditure. This mouse model
might be useful to address the role of leptin signaling in different
neurons without the need to generate conditional knockouts and tar-
geted re-expression of the receptor in global knockouts.
4. DISCUSSION
We discovered a novel spontaneous mutation in the leptin receptor
gene that causes the development of obesity in homozygous mice. The
DNA sequence mutation from G to A has two consequences: it gen-
erates an amino acid exchange (G506S), and it also creates an
additional acceptor site for splicing that, when used, causes a 40
amino acid internal deletion in the receptor (LepRbD40aa). Since the
position of the mutation is close to the leptin binding domain, the
amino acid exchange could affect leptin binding and therefore signal
transduction, irrespective of whether alternative splicing occurred or
not. However, transfection of 3T3 cells with the full length LepRb
transcript encoding the G506S point mutation proved that the ex-
change of this single amino acid did not compromise leptin signaling
(i.e. STAT3 and ERK activation). In contrast, transfection of 3T3 cells
with LepRbD40aa revealed that the alternatively spliced form of leptin
receptor could not be expressed on the cell surface, indicating that
abrogated or impaired cell surface expression, rather than impaired
leptin binding due to the amino acid exchange, may be the underlying
reason for the development of obesity in mice carrying this mutation.
Since we found both spliced (LepRbD40aa) and unspliced transcripts
with the G506S mutation in the medio-basal hypothalamus of homo-
zygous LepRbG506S/G506S mice, we consider two likely scenarios.
LepRbD40aa may exert a dominant negative effect on LepRbG506S, as
LepRb needs to dimerize to allow translocation to the cell surface [2].
Association of LepRbD40aa with LepRbG506S monomers could prevent a
functional dimerization of the receptor and therefore abrogate cell
surface expression. Alternatively, the level of functionally intact
LepRbG506S dimers on the cell surface could be too low to reach a
threshold required for optimal signaling. The two possibilities are not
mutually exclusive.
Leptin-induced pSTAT3 analysis revealed that leptin signaling was
differentially affected in neurons localized in the DMN, VMN and ARC of
the mutated mice. Abrogated signaling in response to exogenous leptin
was observed in the VMN and in the DMN, suggesting that the Lep-
RbD40aa product predominates in these neurons and prevents
responsiveness to leptin in this region. On the other hand, leptin
signaling was only halved in the ARC. Interestingly POMC neurons in
the ARC of LepRbG506S/G506S mice showed normal pSTAT3 activation in
response to leptin, suggesting that reduced signaling in the ARC may
be caused by defective LepRb signaling in AgRP neurons. Unfortu-
nately, staining of AgRP neurons in brain sections to verify this hy-
pothesis is not possible. To reach a more deﬁnitive conclusion,
selective depletion of AgRP neurons in LepRG506S/G506S mice will be
required, for instance by crossing them to AgrpDTR mice [47], which
still remains to be done. However AgrpDTR LepRG506S/G506S mice may
have additional phenotypes caused by other functions of AgRP neurons
independent of leptin.
We propose that the reduced number of pSTAT3þ cells found in the
ARC is due to a difference in the efﬁciency of alternative splicing
among different neuron populations, leading to efﬁcient alternative
splicing of the mutant LepRb transcript in SF1 neurons of the VMN and
AgRP in the ARC but not in POMC neurons, possibly due to a different
distribution of splicing factors. Since we hypothesized that the
decrease in pSTAT3 signaling may be taking place in AgRP neurons
and that no signal is present in VMN and DMN neurons, AgRP, VMN,
and DMN neurons would be predicted to have similar splicing patterns
generating the truncated LepRb protein that does not respond to leptin.
This may be the underlying molecular reason for the differences in
metabolic dysfunctions between LepRbG506S/G506S mice and db/db
mice. The development of a massive obesity due to a defect in the
inhibition of food intake is comparable in the two strains even though
POMC signaling is maintained in the mutated mice. Interestingly,
previous experiments showed that selective reconstitution of LepRb
expression in AgRP neurons in db/db mice prevented uncontrolled food
intake and obesity [37]. In contrast, selective depletion of leptin re-
ceptor in the VMN did not change food intake on normal chow diet
[32,33]. Similarly, depletion of LepRb from DMN neurons did not have
any effect in food intake [38]. These data suggest that AgRP neurons in
the ARC rather than VMN or DMN neurons play a pivotal role in the
control of food intake. Furthermore, selective depletion or expression of
the leptin receptor on POMC neurons does not change food intake
[34,35]. Thus, obesity and dysregulated food intake in LepRbG506S/
G506S mice is most likely explained by defective signaling of the Lep-
RbD40aa in AgRP neurons.
Even more interesting than the similarity in the development of obesity
of db/db and LepRbG506S/G506S mice are the quantitative differences in
glucose intolerance and fat accumulation. Fasting plasma glucose was
lower in LepRbG506S/G506S compared to db/db mice, despite compa-
rable body weight. Based on the altered leptin signaling observed in
LepRbG506S/G506S mice, we speculate that improved glucose tolerance
results from intact function of POMC neurons in the ARC. Although we
cannot deﬁnitively conclude that this is due to a direct role of POMC
neurons in the regulation of glucose homeostasis or rather by an in-
direct effect caused by the different body composition and slightly
lower body weight of LepRbG506S/G506S mice compared to db/db mice,
we favor the second hypothesis based on the data obtained.
Normalization of fasting plasma glucose by body weight showed that
LepRbG506S/G506S were comparable to lean littermates, while db/db
mice had signiﬁcantly higher plasma glucose, even when normalized.
Notably, insulin resistance was comparable in LepRbG506S/G506S and
db/db mice. This indicates that the improved control of glycemia in
LepRbG506S/G506S compared to db/db mice occurs by an indirect
mechanism such as reduced accumulation of adipose tissue in
LepRbG506S/G506S mice. Most likely, the increased amount of food
consumed by LepRbG506S/G506S mice is more efﬁciently converted into
lean mass than in db/db mice.
It has been suggested previously that LepRb in the ARC, and in
particular POMC neurons, play a major role controlling glucose
homeostasis [35]. Melanocortin, which is produced by POMC
neurons upon leptin stimulation, plays a crucial role in the regu-
lation of glucose uptake by muscle cell. While food intake was
unchanged, the amount of abdominal fat was reduced by treatment
with a-MSH, and the response to insulin was potentiated, whereas
melanocortin receptor antagonist mediated the opposite effect [48].
We also observed less subcutaneous fat in LepRbG506S/G506S mice
compared to db/db. A plausible explanation is that the melano-
cortin system is at least partially intact in LepRbG506S/G506S mice,
which is consistent with normal leptin-induced STAT3 activation
observed in the POMC population. An intact melanocortin system
may limit fat accumulation and ensure a better glycemic control
without affecting food consumption. Indeed, mice expressing
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LepRb only on POMC neurons (LeprloxTB  POMC-cre mice) show
obesity and food intake comparable to a full body LepRb KO, while
energy expenditure, glycemia, and insulinemia were almost normal
[35]. From 12 weeks of age LeprloxTB  POMC-cre mice start to
display a difference in body weight compared to global LeprloxTB
KO with global deletion, which is entirely due to less accumulation
of fat mass. In addition, LepRb expression exclusively in POMC
neurons reduced plasma cholesterol compared to global KO and
restored triglycerides to levels of WT. Similarly, LepRbG506S/G506S
mice with intact LepRb signaling in POMC neurons but defective
LepRb in SF1 and AgRP neurons show improvement in glycemia,
insulinemia, and accumulation of adipose tissue and plasma tri-
glycerides compared to db/db mice. In addition, their energy
expenditure is comparable to WT lean mice and, at day time, lower
than in db/db. A possible explanation is that uncontrolled food
intake during the day time accounts for increased expenditure in
db/db mice, whereas the other groups rest during the day and
therefore their energy expenditure is signiﬁcantly lower and also
lower than night time when they are more active [49].
These observations strongly support the hypothesis that alternative
splicing of the LepRb occurs with different efﬁciencies in different
neurons, thus abrogating the signal completely in some and leaving it
almost intact in others. As a consequence, hyperphagic, obese mutant
mice are able to control energy expenditure, reducing the accumula-
tion of adipose tissue and ensuring improved glucose tolerance even
by insulin resistance.
This natural mutation should be useful to separately and speciﬁcally
study the role of leptin signaling in hypothalamic VMN and ARC and
metabolic consequences.
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